A ribonucleic acid (RNA) hybridization assay to identify cattle infected by bovine viral diarrhea virus (BVDV) is described. The RNA probe was derived from the coding region at the 3' end of the genome of the NADL strain of BVDV. Total RNA from infected cell cultures or peripheral blood leukocytes from suspect animals was extracted and applied to nylon membranes with a slot blot apparatus. Peripheral blood leukocytes were tested concurrently for BVDV by virus isolation. The results of hybridization and virus isolation were in agreement for 92% of the cases. When compared with virus isolation, hybridization had a sensitivity of detection of 59.5% and a specificity of 95%. Cross-reactivity to RNA extracts of border disease virus-infected cells was noted. No cross-reactivity was detected to other common bovine viruses (bovine herpesvirus-l, bovine respiratory syncytial virus, parainfluenza-3 virus, and bluetongue virus), to viruses classified in related families (equine arteritis virus and Venezuelan equine encephalitis virus), or to viruses having similar genomic organization (dengue virus type 2 and Japanese encephalitis virus).
Bovine viral diarrhea virus (BVDV) is a nonarthropod-borne member of the Togaviridae, genus Pestivirus. It is a small (40-60 nm) enveloped 3, 11 positivesense RNA virus. 8 Bovine viral diarrhea virus has a worldwide distribution with reported serum antibody prevalence in cattle of 50-90%. 1 Infections caused by BVDV result in a significant financial loss to the beef and dairy industries annually. 15 Bovine viral diarrhea virus causes a relatively mild, often subclinical disease in mature immunocompetent animals. Clinical symptoms may include a slight fever accompanied by a transient decrease in total lymphocytes and mild diarrhea. 5, 16 In contrast, fetal exposure may result in abortion, congenital defects, or chronic infection of the calf. Chronically infected calves are predisposed to mucosal disease (MD), which is much more debilitating than acute BVDV infection. Mortality rates from MD >50% have been observed in persistently infected calves in the first year of life. 9 The exact pathogenic mechanisms at work in the BVDV-MD complex are not well understood. It is clear that the same agent that causes only a mild disease in acutely infected animals is capable of inducing fatal MD in persistently infected cattle. In MD cases, a dual infection with 2 biotypes, cytopathic and noncytopathic BVDV, is almost always found and may be a significant factor in BVDV-MD pathogenesis. 2, 5, 6, 9, 14 The 2 variants (or biotypes) of BVDV isolated from field cases are distinguished by their effect on cultured cells. The cytopathic biotype, BVDV-cp, causes characteristic formation of large vacuoles in the infected cell cytoplasm, giving it a "foamy" appearance, whereas the noncytopathic biotype, BVDV-ncp, causes no visible cellular changes. Detection and confirmation of BVDV requires immunochemical staining of infected cells, using such techniques as immunofluorescence or immunoperoxidase staining. Two to 5 subpassages may be necessary to infect sufficient numbers of cells for detection by staining. Cell lines of bovine origin may unknowingly be contaminated with BVDV-ncp and remain persistently infected. Additionally, BVDV or BVDV antibodies are often found as contaminants of fetal bovine serum used for cell culture work. Accurate, sensitive, and rapid detection of BVDV from both field and laboratory sources would be advantageous in diagnosis and control of disease. Current means of diagnosing acute BVDV infection or identifying animals predisposed to MD require virus isolation (VI) in conjunction with detection of serum antibodies. These methods are labor intensive and time consuming and are not easily adaptable to rapid processing of large numbers of samples. Although nucleic acid hybridization is also labor intensive, the results can be obtained sooner than from VI and the procedure may be modified to accommodate large samples. The purpose of this study was to develop and evaluate an RNA hybridization assay for the identification of cattle infected with BVDV.
Materials and methods
Cell culture. Madin-Darby bovine kidney (MDBK) cells or bovine turbinate (BT) cells were used for BVDV growth in vitro. Both cell lines were shown to be BVDV-free by immunocytochemical staining using a monoclonal antibody (D89) specific for gp53, 12 ,17 1 of the major envelope glycoproteins of BVDV. During assay development, the 2 cell lines were also routinely tested by hybridization and were free of BVDV sequences. Dulbecco's modified Eagle's Minimum Essential Medium (DMEM) a was used for cell and virus growth. The complete growth medium consisted of DMEM supplemented with 10% gamma-irradiated heat-inactivated fetal bovine serum, b 0.292 mg/ml L-glutamine, c 50 µg/ml streptomycin sulfate, d and 100 U/ml penicillin G. d Viruses.
Five strains of BVDV were tested for their ability to hybridize to the RNA probe: NADL, Singer, and Oregon (cytopathic strains), and NY-1 and Draper (noncytopathic strains). e In addition to these, other taxonomically related viruses and commonly isolated bovine viruses were tested, including bluetongue virus (BTV), bovine respiratory syncytial virus (BRSV), parainfluenza-3 virus (PI-3), bovine herpesvirus-l (BHV-1) border disease virus (BDV) of sheep, and equine arteritis virus (EAV). f All viruses except BTV were inoculated onto nearly confluent monolayers of MDBK or BT. Bluetongue virus was grown in Vero cells that had previously tested negative for BVDV by VI and hybridization. Cell cultures were inoculated with a multiplicity of infection (moi) equal to 0.2 TCID 50 per cell. At 48 hr postinfection, the monolayers were frozen at -70 C and subsequently used for RNA extractions. Viral RNA from dengue virus type 2 (DEN-2), g Japanese encephalitis virus (JEV), g and Venezuelan equine encephalitis virus (VEEV) h were also tested for hybridization with the probe. Virus stocks of BVDV consisted of clarified supernatant fluid from infected monolayers that were frozen at -70 C at 72 hr postinfection. Virus titers typically ranged from 4 × 10 4 to 1.5 × 1 0 5 TCID 50 /ml for NY-1, the noncytopathic prototype strain of this study.
Clinical specimens and other virus isolates. Clinical specimens consisted of whole unclotted blood drawn by venipuncture from animals in herds with histories consistent with BVDV infection. The blood specimens were transported cold (4 C) and tested by VI at the Veterinary Diagnostic Laboratory at Colorado State University. Hybridization was concurrently performed on a duplicate blood sample for each case. Hybridization was also performed on RNA extracts of cell cultures infected with 20 additional BVDV strains previously isolated from peripheral blood leukocytes (PBL) or other clinical specimens from suspect animals and identified as BVDV by VI.
Immunocytochemical staining. The presence and titer of the noncytopathic BVDV NY-l strain were determined by immunoperoxidase staining. This technique utilized an anti-gp53 monoclonal antibody (MAb) D89 12 and an avidin-biotin-peroxidase complex kit i that produced a colored precipitate product in the cytoplasm of BVDV-infected cultured cells. 17 Typically, either MDBK or BT cells were seeded at approximately 2 × 10 4 cells per 0.79 cm 2 area of an 8-chamber cell culture slide. j After cells attached, they were inoculated with serial dilutions of the virus stock. At 72 hr postinfection, the cells were fixed with acetone and stained.
Virus isolation. Peripheral blood leukocytes were isolated from 10 ml of unclotted blood and inoculated onto nearly confluent monolayers of BT cells. Blood was centrifuged at 300 × g for 10 min in a table-top clinical centrifuge and the buffy coat layer removed with a sterile pasteur pipet. Any red blood cells in the buffy coat fraction were lysed by mixing with 3 volumes of cold lysis buffer (0.01 M Tris, pH 7.4, in 0.85% w/v NH 4 Cl) and then chilling on ice for 15 min. The buffy coat leukocytes were collected by centrifuging at 300 × g for 10 min and inoculated onto cell cultures. If, after 10-14 days of incubation, no cytopathic effect was observed, the culture was trypsinized and passaged onto fresh BT cells in the 8-chamber cell culture slide. After 3 days of incubation, these slides were fixed in acetone and stained by immunoperoxidase.
RNA extractions. Frozen infected monolayers and medium were thawed and centrifuged at 250 × g for 10 min. The material remaining in the supernatant was precipitated by addition of 2.2% sodium chloride and 7% polyethylene glycol-8000 (PEG) (final concentrations). After gentle stirring at 4 C for 10-18 hr, the PEG precipitate was pelleted by centrifugation at 11,000 × g for 30 min at 4 C. This pelleted material was extracted in an acid guanidinium thiocyanatephenol-chloroform mixture (AGPC). 7 The PEG precipitate was dissolved in a 4 M guanidinium thiocyanate solution (4 M guanidinium thiocyanate, d 25 mM sodium citrate, d p H 7.0, 0.5% sarcosyl, d 0.1 M 2-mercaptoethanol d ), using 0.1 ml/10 6 cultured cells. This solution was then extracted by the addition of 0.1 volume 2 M sodium acetate, d pH 5.2, 1.0 volume water-saturated phenol, k and 0.2 volume chloroform : isoamyl alcohol d (49:1). The final mixture was vigorously vortexed, chilled on ice for 15 min, then centrifuged to separate the phases at 11,000 × g for 20 min at 4 C. The aqueous phase was removed, and the RNA was precipitated with an equal volume of isopropanol at -20 C overnight. The final RNA pellet was resuspended in 0.1 ml of distilled water previously treated with diethylpyrocarbonate (DEPC). d Buffy coat leukocytes from 10 ml of blood were isolated, suspended, and lysed in 4 M guanidinium thiocyanate solution and then extracted using the AGPC method. The final RNA pellet was resuspended in 0.1 ml of DEPC-treated distilled water.
All glassware for RNA work was baked for 9 hr at 65 C. Plasticware items were vigorously shaken in a 0.1% solution of DEPC for 2-3 hr; the DEPC was then inactivated by autoclaving. Solutions were directly treated with 0.1% DEPC then autoclaved to inactivate the DEPC or prepared in DEPCtreated autoclaved distilled water.
Plasmids and probe preparation. Plasmids were maintained in Escherichia coli, strain HB 101, and purified using standard methods. 13 The BVDV sequence used for hybridization probes and controls was a molecularly cloned 1,651base pair cDNA, encompassing nucleotides 9,866-11,516 8 of the NADL strain BVDV 1 genome. The RNA transcripts of this cDNA fragment were obtained after subcloning the BVDV-specific cDNA into a pGEM1 plasmid, m creating pKR1.1. The multiple cloning site of pGEM1 is flanked by the bacteriophage SP6 and T7 RNA polymerase promoters, allowing for transcription of either virus genome-sense or complementary RNA. The RNA probe, complementary to BVDV genomic RNA, was produced from the T7 RNA polymerase promoter. This probe was referred to as the anti- sense RNA probe and was labeled during in vitro transcription by incorporation of alpha-32 P-UPT n using a commercially available kit. m The unincorporated nucleotides and enzymes were removed by 2 phenol : chloroform extractions followed by 2 ethanol precipitations at -20 C overnight. The final RNA pellet was resuspended in 20 µ1 of DEPC-treated distilled water and stored at -20 C. Probes labeled in this manner typically contained 2 × 10 8 cpm/µg and were used within 10 days of preparation. Genome-sense RNA was also transcribed from pKR1.1 using the SP6 RNA polymerase promoter. These transcripts were not radioisotope labeled but were denatured, diluted, and affixed to the nylon membranes o as a hybridization control. Transcription and purification of virus-sense RNA was carried out in the same manner as for the radiolabeled probe.
Slot blot and hybridizations. Hybridizations were carried out on nylon membranes. The RNA to be hybridized was first denatured at 60 C for 15 min in the following solution: 50 µ1 RNA, 30 µ1 20 × SSC (1 × SSC is 0.15 M sodium chloride and 0.015 M sodium citrate), and 20 µ1 37% formaldehyde solution. The RNA was then diluted in 20 × SSC, applied to the membrane with a slot blot vacuum manifold," and fixed on the membrane by baking in an 80 C oven for 2 hr followed by UV-cross linking for 2 min. The UV source emitted 0.14 watts at 254 nm, and the filter was 18 cm from the source. Generally, membranes were prehybridized immediately after fixing, but some were held dry at 4 C in a sealed plastic bag for up to 2 wk prior to hybridization without a noticeable decrease in signal. Prehybridizations and hybridizations for the anti-sense RNA probe were performed in heat sealed bags p in a shaking water bath at 65 C, unless otherwise indicated. Prehybridization solution consisted of 50% deionized formamide, k 5 × SSC, 5 × Denhardt's solution (1mg/ml Ficoll, d 1 mg/ml polyvinylpyrrolidone, d and 1 mg/ml BSA fraction V d ), 0.2% sodium dodecyl sulfate (SDS), d 0.2 mg/ml wheat germ tRNA, d and 0.2 mg/ml denatured salmon sperm DNA. d The hybridization solution contained the above reagents plus 1-2 × 10 6 cpm of 32 P-UTP-labeled RNA probe per 4 ml of solution and 0.2 volume of 50% dextran sulfate. Prehybridizations were carried out for 2 hr and hybridizations for 16-18 hr. Volumes of prehybridization and hybridization solutions were 0.1 ml/cm 2 of nylon membrane. Posthybridization washes were also carried out at 65 C, 3 times for 20 min each, in 250 ml 0.1 × SSC and 0.1% SDS unless otherwise indicated. The membranes were air dried briefly following washing then exposed to x-ray film q for 24 hr at -70 C, using intensifying screens. Under these hybridization and wash conditions, hybrids must have ≥ 83% complementarity to remain as stable duplexes. 10
Results

Sensitivity of hybridization. A determination was
made of sensitivity of the hybridization assay using known amounts of the virus-sense transcript employed as a positive hybridization control. This RNA could consistently be detected at 25 pg ( Fig. 1) , which represented approximately 1.4 × 10 5 genome equivalents.
Sensitivity was also determined by hybridization of RNA extracted from BVDV NY-1 strain-infected cell culture supernatant fluid. The infectious titer of the supernatant was 3.2 × 1 0 5 TCID 50 /ml. Bovine viral diarrhea virus-specific RNA extracted from this supernatant was detected at a maximum dilution of 1:125, or 1.25 × 1 0 4 TCID 50 (Fig. 2) .
Specificity of hybridization.
Hybridization with the anti-sense RNA probe was specific under the stringent conditions used. The probe hybridized to all 5 tested strains of BVDV. Greater signal was observed with the cytopathic strains Singer and Oregon than with the noncytopathic strains NY-l and Draper (Fig. 3) . The reactivity to NADL, also a cytopathic strain, resembled that of the noncytopathic strains because of the reduced amount of NADL RNA applied to the blot (see Fig. 3 legend) . On previous blots where equal amounts of RNA extracts of the 3 cytopathic strains were applied, all reacted similarly (data not shown). A summary of the specificity testing for hybridization is shown in Table 1 . No reactivity was seen to RNA from the flaviviruses JEV and DEN-2 or from the togaviruses VEEV and EAV. In addition, there was no hybridization to nucleic acid extracts from cells infected with other commonly isolated bovine viruses, BHV-1, BTV, BRSV, or PI-3 (data not shown). Some reactivity to BDV, an antigenically related pestivirus, was seen. However, only 1 of 3 BDV isolates was detected by hybridization, even when stringency was reduced by carrying out hybridization and washes at 50 C (data not shown).
Detection of BVDV from clinical specimens. Peripheral blood leukocytes from 399 animals were tested by both hybridization and VI. By hybridization, 359 samples tested negative and 40 tested positive. By VI, 362 samples tested negative and 37 tested positive ( Table 2) . Twenty-two animals tested positive by both methods, for an agreement of 92%. Eighteen animals tested positive by hybridization but negative by VI, and 15 animals tested negative by hybridization but positive by VI. Ten specimens that tested negative by hybridization but positive by VI were rehybridized after 3 additional passages in vitro; all 10 tested positive. Of samples that were hybridization positive but from which no virus was isolated, 5 were selected and passaged 3 more times without becoming positive. Additionally, the original inoculum (saved at -70 C) was recultured for 5 passages without recovery of the virus. The results of these experiments indicate that there were at least 10 false negative initial hybridization results but do not necessarily indicate that there were false positive hybridization results, despite the absence of isolated virus. The sensitivity and specificity of the hybridization protocol were calculated using VI results as the referent standard. Sensitivity of hybridization was 59.5% (22/ 22 + 15) and the specificity was 95% (344/344 + 18) in reference to VI results for the clinical specimens tested ( Table 2 ).
Discussion
Traditional methods for the detection of BVDV in biological specimens have required coculture with a susceptible cell line, often requiring 2-5 subpassages to allow for virus amplification. Subsequent detection of viral antigen in cultures requires BVDV-specific antibodies and immunochemical techniques. The hybridization assay described here provides a means of directly identifying BVDV RNA in PBL of infected cattle without biological amplification or subsequent immunochemical staining. Peripheral blood leukocytes are a readily available source of BVD viral genomes for hybridization. In a study of BVDV-infected animals, 9-30% of circulating PBL harbored intracellular viral antigen, and the yield of cell-associated virus was 32-1,924 TCID 50 /10 6 PBL. 4 The sensitivity of BVDV-specific hybridization was calculated in 2 ways. Virus-sense RNA was transcribed from pKRl.1 in vitro and used as a positive hybridization control. This RNA was consistently detected at 25 pg. The RNA extracted from NY-1-infected cell culture supernatant with a known infectious titer was detected at 1.25 x 10 4 TCID 50 .
Bovine viral diarrhea virus, particularly the BVDVncp strains, is known to grow to low virus titers in vitro and in vivo. This may explain why multiple subpassages of PBL cocultures are necessary to detect BVDV by VI. Results from this study indicate that in vitro amplification may also be necessary prior to nucleic acid hybridization to ensure accurate diagnosis. Of the 399 animals screened by VI and hybridization, 15 (3.76%) tested negative by hybridization but positive by VI after the second passage. The RNA extracts from 10 of these cases were rehybridized after 3 passages in vitro and tested positive.
In comparison, 18 of the 399 animals (4.5 1%) tested positive by hybridization but negative by VI at the second passage. Five of these cases were carried through 3 more subpassages in culture and remained negative by VI at the fifth passage. These results may indicate cross-hybridization of the probe sequences to non-BVDV sequences extracted with the total RNA from PBL. However, cross-hybridization is unlikely because of the high stringency of hybridization and posthybridization washes. Additionally, no cross-reactivity of this BVDV probe was seen with nucleic acid extracts made from uninfected cell cultures or cultures infected with commonly isolated bovine viruses. Another possible explanation for the discrepancy between the hybridization and VI results is that the negative VI was erroneous. For example, presence of virus may have been missed because of the inability of the anti-BVDV-gp53 MAb to recognize and bind cells infected after coculturing with PBL. A single amino acid change in the gp53 antibody recognition site of a BVDV strain could prevent recognition and thus the VI would appear as a BVDV-negative culture.
The cases that tested negative by VI but positive by hybridization could be explained in another manner. Virus isolation utilizes a biological system that must be productively infected to test positive by immunochemical staining. Theoretically, VI should be capable of detecting 1 virus particle or 1 infected leukocyte. However, the virus and/or leukocyte must be undamaged and alive, and virus must be transferred from PBL to the cultured cell monolayer. Not all virus particles or cells from a biological specimen are infectious; many may be noninfectious because of length or inappropriate conditions of transport of the specimen. Furthermore, defective or noninfectious viruses may interfere with attachment or replication of infectious virions. In comparison, molecular hybridization can detect viral genomic sequences from defective or inactivated virions as well as infectious virions.
If it is assumed that most of the hybridization-positive VI-negative cases were truly positive, the specificity of the hybridization would increase dramatically and approach 100%. Even though the hybridization probe has the ability to detect virus that was noninfectious, direct detection of live BVDV by molecular hybridization is not extremely sensitive, as shown by the false negative hybridization results. Prior amplification of virus RNA by growth in vitro or by enzymatic means may be necessary to detect BVDV from specimens with low titers of BVDV.
Hybridization of the anti-sense BVDV RNA probe to border disease viral RNA extracts was expected be-cause of the documented serologic cross-reactivity between the 2 viruses. Only 1 of 3 isolates reacted under the standard hybridization and wash conditions. The same isolate reacted under reduced stringency conditions, which allowed duplexes of ≥ 75% homology to remain intact, whereas the standard hybridization and wash conditions required ≥ 83% homology for stable duplexes. 10 The lack of hybridization to 2 of the 3 BDV isolates tested suggests a significant sequence variation in the nonreactive BDV genomes. However, the possibility of negative hybridization results due to insufficient virus growth and number of genome copies in the RNA extract cannot be ruled out.
Nucleic acid hybridization provides an improved diagnostic technique for the detection of viral genomes, although sensitivity of this technique has limitations. The addition of enzymatic amplification (e.g., polymerase chain reaction) could improve sensitivity while preserving the advantages of specificity and speed.
